BioNeutral Group Inc. (fka BONU)

[HAE12]

BioNeutral Group's YGIENE(TM) 206 Sterilant Offers High Performance Alternative for Ebola Surface Decontamination
Accesswire
59 minutes ago
????
NEWARK, NJ / ACCESSWIRE / October 21, 2014 / BioNeutral Group Inc. (OTC Pink: BONU) (BONU), a specialty life science technology based company today addressed the Ebola decontamination issue. Surfaces contaminated with Ebola pose a threat in the spread of this disease. While other disinfectants may be used to decontaminate surfaces containing Ebola, the Company believes that none can offer the level of decontamination efficacy and efficiency offered by YGIENE(TM) 206 Sterilant which eliminates all harmful microorganisms. YGIENE(TM) 206 Sterilant is the fastest ready to use sterilant with a 20 minute kill time, and is chlorine and aldehyde free. YGIENE(TM) 206 Sterilant provides an extra level of confidence in eliminating Ebola in addition to other harmful microorganisms on contaminated surfaces either by wetting surfaces or immersing contaminated articles.

YGIENE(TM)Sterilant/Disinfectant is registered with the US EPA as a sterilant with a 20 minute contact time. As a sterilant, YGIENE(TM) 206 kills all harmful microbial life including Ebola as long as the nonporous surface has contact with YGIENE(TM) for the full 20 minutes.

As indicated on the YGIENE(TM) 206 Sterilant label: "a sterilizer is an antimicrobial pesticide that destroys or eliminates all forms of microbial life in the inanimate environment, including bacterial spores. The term "sporicide" is deemed to be synonymous with "sterilizer". Since sterilization includes eradication of all living microorganisms, such claims are intrinsically related to protection of human health (EPA DIS/TSS-9)."

The Company believes that the ease of application and this high level of broad spectrum efficacy sets the ready to use YGIENE(TM) 206 Sterilant apart from other available disinfectants.

About BioNeutral Group, Inc.:

Headquartered in Newark, New Jersey, BioNeutral Group, Inc., is a specialty technology-based life-science company that has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, YGIENE(TM) and OGIENE(TM), kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the YGIENE(TM) brand have been approved by the EPA for sale in the United States. For more information on BioNeutral, including a listing of company products, leadership and background please visit www.bioneutral.com.

Find us on Facebook: http://www.facebook.com/pages/BioNeutral-Group/149109938452393

Follow us on Twitter: http://twitter.com/bioneutralgroup

Forward-Looking Statements:

This release contains certain "forward-looking statements" relating to the business of the Company and its subsidiary companies. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those described in the Company's filings with the Securities and Exchange Commission. BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA has approved and registered the Company's data and findings specific to YGIENE(TM)206 Sterilant. BioNeutral's antimicrobial formulations will be marketed under the brand name YGIENE(TM) and are available for sale in the United States.

CONTACT:

Mark Lowenthal
CEO and Sales Information for BioNeutral Group, Inc.
[phone]

SOURCE: BioNeutral Group, Inc.